Aigen Investment Management LP acquired a new stake in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 3,859 shares of the specialty chemicals company's stock, valued at approximately $366,000.
Several other institutional investors also recently bought and sold shares of IOSP. Financial Harvest LLC purchased a new position in shares of Innospec in the 1st quarter valued at approximately $41,107,000. Brown Advisory Inc. purchased a new stake in shares of Innospec during the first quarter valued at $31,212,000. Raymond James Financial Inc. acquired a new position in shares of Innospec in the 4th quarter valued at $20,992,000. Victory Capital Management Inc. raised its stake in Innospec by 20.0% in the 1st quarter. Victory Capital Management Inc. now owns 1,106,482 shares of the specialty chemicals company's stock worth $104,839,000 after acquiring an additional 184,262 shares during the last quarter. Finally, Westwood Holdings Group Inc. lifted its position in Innospec by 28.3% during the 1st quarter. Westwood Holdings Group Inc. now owns 382,410 shares of the specialty chemicals company's stock worth $36,233,000 after acquiring an additional 84,314 shares during the period. 96.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages have recently issued reports on IOSP. Seaport Res Ptn upgraded Innospec from a "hold" rating to a "strong-buy" rating in a research note on Monday, April 21st. Wall Street Zen lowered shares of Innospec from a "buy" rating to a "hold" rating in a research report on Tuesday, May 6th.
Check Out Our Latest Analysis on Innospec
Innospec Price Performance
NASDAQ IOSP traded up $0.86 during trading hours on Monday, reaching $83.80. The company's stock had a trading volume of 29,340 shares, compared to its average volume of 203,851. The firm has a market capitalization of $2.08 billion, a price-to-earnings ratio of 107.44 and a beta of 1.07. The company's 50-day moving average is $84.36 and its two-hundred day moving average is $91.25. Innospec Inc. has a 1-year low of $74.10 and a 1-year high of $128.35.
Innospec (NASDAQ:IOSP - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.09. Innospec had a net margin of 1.08% and a return on equity of 10.89%. The company had revenue of $439.70 million during the quarter, compared to analysts' expectations of $440.70 million. During the same period in the prior year, the business posted $1.39 earnings per share. The firm's revenue for the quarter was up 1.1% on a year-over-year basis. Equities analysts forecast that Innospec Inc. will post 6.18 EPS for the current fiscal year.
About Innospec
(
Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
See Also

Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.